20 Matching Annotations
  1. Dec 2025
  2. pmc.ncbi.nlm.nih.gov pmc.ncbi.nlm.nih.gov
    CAR binders affect CAR T-cell tonic signaling, durability, and sensitivity to target
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    pmc.ncbi.nlm.nih.gov/articles/PMC12137003/
  3. Mar 2025
  4. www.sciencedirect.com www.sciencedirect.com
    CDK4 selective inhibition improves preclinical anti-tumor efficacy and safety
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610825000583
  5. Feb 2025
  6. ashpublications.org ashpublications.org
    CD70-specific CAR-NK cells expressing IL-15 for the treatment of CD19-negative B cell malignancy
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ashpublications.org/bloodadvances/article/8/11/2635/515576/CD70-specific-CAR-NK-cells-expressing-IL-15-for
  7. Dec 2024
  8. www.sciencedirect.com www.sciencedirect.com
    YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S0092867424013242
  9. Sep 2024
  10. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    TFAB002s, novel CD20-targeting T cell-dependent bispecific Fab-FabCH3 antibodies, exhibit potent antitumor efficacy against malignant B-cell lymphoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11423992/
  11. Jul 2024
  12. 52.53.155.43 52.53.155.43
    ajcr0151293-html.html
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    52.53.155.43/3e506c81eb294633d25ccb146c7b74591d49000f/ajcr0151293-html.html
  13. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Chidamide represses MYC expression and might improve survival for patients with double expressor lymphoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11236771/
  14. May 2024
  15. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Novel Spirocyclic Dimer, SpiD3, Targets Chronic Lymphocytic Leukemia Survival Pathways with Potent Preclinical Effects
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC11110724/
  16. Jan 2024
  17. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Safety and feasibility of anti-CD19 CAR T cells expressing inducible IL-7 and CCL19 in patients with relapsed or refractory large B-cell lymphoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10774422/
  18. Nov 2023
  19. www.sciencedirect.com www.sciencedirect.com
    Therapeutic targeting of EP300/CBP by bromodomain inhibition in hematologic malignancies
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S1535610823003665
  20. www.nature.com www.nature.com
    Preclinical evidence for the effective use of TL-895, a highly selective and potent second-generation BTK inhibitor, for the treatment of B-cell malignancies
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    nature.com/articles/s41598-023-47735-z
  21. Jul 2023
  22. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    Preclinical Evidence of an Allogeneic Dual CD20xCD22 CAR to Target a Broad Spectrum of Patients with B-cell Malignancies
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC10320475/
  23. Apr 2023
  24. aacrjournals.org aacrjournals.org
    IOA-244 is a Non–ATP-competitive, Highly Selective, Tolerable PI3K Delta Inhibitor That Targets Solid Tumors and Breaks Immune Tolerance
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    aacrjournals.org/cancerrescommun/article/3/4/576/725855/IOA-244-is-a-Non-ATP-competitive-Highly-Selective
  25. Nov 2022
  26. www.mdpi.com www.mdpi.com
    Bcl-2 Family Members Bcl-xL and Bax Cooperatively Contribute to Bortezomib Resistance in Mantle Cell Lymphoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    mdpi.com/1422-0067/23/22/14474
  27. Oct 2021
  28. www.sciencedirect.com www.sciencedirect.com
    Lymphocyte access to lymphoma is impaired by high endothelial venule regression
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124721013486
  29. Aug 2021
  30. bpspubs.onlinelibrary.wiley.com bpspubs.onlinelibrary.wiley.com
    A non‐covalent inhibitor XMU‐MP‐3 overrides ibrutinib‐resistant BtkC481S mutation in B‐cell malignancies
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    bpspubs.onlinelibrary.wiley.com/doi/10.1111/bph.14809
  31. Jul 2021
  32. www.ncbi.nlm.nih.gov www.ncbi.nlm.nih.gov
    CAR T cells targeting αvβ3 integrin are effective against advanced cancer in preclinical models
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    ncbi.nlm.nih.gov/pmc/articles/PMC6226260/
  33. www.sciencedirect.com www.sciencedirect.com
    ASN007 is a selective ERK1/2 inhibitor with preferential activity against RAS-and RAF-mutant tumors
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2666379121001993
  34. May 2021
  35. clincancerres.aacrjournals.org clincancerres.aacrjournals.org
    A Cyclin D1–Dependent Transcriptional Program Predicts Clinical Outcome in Mantle Cell Lymphoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    clincancerres.aacrjournals.org/content/27/1/213
  36. Mar 2021
  37. www.sciencedirect.com www.sciencedirect.com
    Transcriptional programming drives Ibrutinib-resistance evolution in mantle cell lymphoma
    1
    Visit annotations in context

    Tags

    Annotators

    URL

    sciencedirect.com/science/article/pii/S2211124721001844